EP04.09: Influence of clinical and anamnestic factors on the severity of the course and early delivery in pregnant women with COVID‐19
Year: 2024
Type: conference-abstract
Abstract: Finally, none of the infants in group 1 had anomalies associated with congenital CMV infection, and no adverse effects were reported with valacyclovir.Conclusions: This study confirms the efficacy and safety of valacyclovir as secondary prevention of congenital CMV infection.
DOI: 10.1002/uog.28098
Authors: N. Krivonosova, E.B. Yarovaya, G.S. Krivonosov
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402358188
